WILLINGNESS TO PARTICIPATE IN AIDS VACCINE TRIALS AMONG HIGH-RISK POPULATIONS IN NORTHERN THAILAND

Objectives: To determine the anticipated participation in a prophylact ic AIDS vaccine trial and to identify perceived benefits and barriers to enrollment of HIV-seronegative volunteers at risk of HIV infection in northern Thailand. Design: A cross-sectional survey. Methods: Subje cts interviewed in a cross-sectional survey included female commercial sex workers (n=215), men attending sexually transmitted disease clini cs (n=219), conscripts in the Royal Thai Army (n=1453), and men discha rged from the army (n=293) who had returned to civilian life. We deter mined AIDS vaccine knowledge and attitudes, perceived vulnerability to HIV infection, barriers and incentives to participate in a future vac cine trial and agreement to participate in a randomized trial. Results : Awareness of vaccines (88-97%) and AIDS vaccine development efforts (62-77%) were common and viewed to be a complement to behavior change (74-94%). Approximately 25% of subjects would definitely join a trial if asked, and an additional 38% would accept an AIDS vaccine if they w ere convinced it would be safe and effective. Important barriers to pa rticipation included concerns with discrimination (16-45%), short- (37 -60%) and long-term (30-55%) vaccine side-effects, fear of disability and death (36-58%), and beliefs that partners would refuse to have sex (24-49%) after immunization. The principal inducement to join a trial was health insurance (62%). Conclusion: Potential HIV vaccine trial p articipants have several fears of joining a vaccine study at this time . Information derived from Phase I/II trials is needed to address thes e concerns if enrollment in efficacy trials is to be successful in the near future.